Home LiteratureArticle Details
PMID: 8557972 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy.

Journal of hypertension ·Vol. 13 ·No. 8 ·1995-08-00 ·Pages 933-8

Sawicki PT, Mühlhauser I, Didjurgeit U, Baumgartner A, Bender R, Berger M

Abstract

To determine the prognosis of treated hypertensive type 1 (insulin-dependent) diabetic patients with overt nephropathy. A controlled, prospective, parallel, 5-year follow-up trial. The tertiary care centre of the Heinrich Heine University Hospital in Dusseldorf, Germany. A sequential sample of 91 hypertensive patients with overt diabetic nephropathy participated in a diabetes treatment programme. Thereafter 45 patients received intensified antihypertensive therapy including blood pressure self-monitoring and self-adjustment of antihypertensive drug treatment with the goal of permanent normalization of blood pressure values below 140/90 mmHg. The remaining 46 patients were administered routine antihypertensive therapy and formed the control group. At baseline both groups were comparable in age, sex, metabolic control and renal function. The groups differed at baseline in their duration of diabetes and blood pressure values, which were higher in the intensified antihypertensive therapy group. Total mortality and the need for renal replacement therapy. Blood pressure control was significantly improved in patients who were subjected to intensified antihypertensive therapy, whereas it deteriorated in the group of patients who received routine antihypertensive therapy. At follow-up, primary end points of the study occurred in five (11%) patients of the intensified therapy group and in 19 (41%) patients of the routine therapy group. According to life table analysis, intensified antihypertensive therapy was associated with less frequent primary end points (P = 0.0058) and longer survival (P = 0.01). The differences between the groups remained significant after adjustment for covariates in the proportional hazards model. Participation in a treatment programme aimed at intensification of antihypertensive therapy is associated with a reduction of mortality in hypertensive type 1 diabetic patients with overt nephropathy.

MeSH Terms
Adult Antihypertensive Agents/administration & dosage,therapeutic use Blood Pressure/drug effects Diabetes Mellitus, Type 1/complications,drug therapy,mortality Diabetic Nephropathies/complications,therapy Dose-Response Relationship, Drug Female Humans Male Patient Education as Topic Prognosis Proportional Hazards Models Prospective Studies Renal Replacement Therapy Survival Analysis
Chemicals
Antihypertensive Agents
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Sawicki P T
Medical Department for Metabolic Diseases and Nutrition (WHO Collaborating Centre for Diabetes), Heinrich-Heine University of Düsseldorf, Germany.
Mühlhauser I
Didjurgeit U
Baumgartner A
Bender R
Berger M
Article Info
Journal
Journal of hypertension
Abbr.
J Hypertens
ISSN
0263-6352
Published
1995-08-00
Pages
933-8
Language
English
Region
England
NLM ID
8306882
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com